Experience

Fount Bio, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Member of Board of Directors

  • Oct 2021 - 2 years 3 months

  Boston, Massachusetts, United States Fount Bio is a life science company developing a platform of innovative products for medical applications that combine proprietary innovations in biorthogonal chemistry with glycopolymer science. Fount Bio closed a Series A round of financing led by Morningside Ventures.



Rythera Therapeutics, Inc.

• Executive Chairman of the Board & CEO

  • Sep 2020 - 3 years 4 months

  Miami, Florida, United States Rythera Therapeutics, Inc., is a private biopharmaceutical company focused on novel radio-protective drug product therapies to prevent skin and soft tissue injuries and hair loss caused by ionizing radiation therapy (RT) used in the treatment cancer and fluoroscopic procedures. Current pipeline focused on breast cancer, head & neck cancer and prostate cancer.



Galderma

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Member of the Board of Directors

  • Jul 2020 - 3 years 6 months

  Lausanne, Switzerland Galderma, the world’s largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetic solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin… Show more Galderma, the world’s largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetic solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galderma.com. Show less



Avava

• United States
• Medical Device
• 1 - 100 Employee

• Member of the Board of Directors

  • Dec 2020 - May 2022

  Boston, MA, USA Avava is a medical technology company innovating and commercializing breakthrough platform technology to safely and effectively treat melasma and hyperpigmentation, and rejuvenate skin of color and the entire range of skin tones found across the world.



Revance Therapeutics

• United Kingdom
• Retail Office Equipment
• 1 - 100 Employee

• Co-Founder & President & CEO

  • Jan 2002 - Oct 2019

  Newark, CA Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DAXXIFY. DAXXIFY or DaxibotulinumtoxinA for Injection non-covalently assembles a proprietary stabilizing peptide excipient with a highly purified botulinum toxin that does not contain human or animal-based components. Revance successfully completed a Phase 3 program for DAXXIFY in glabellar (frown) lines and received FDA regular… Show more Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DAXXIFY. DAXXIFY or DaxibotulinumtoxinA for Injection non-covalently assembles a proprietary stabilizing peptide excipient with a highly purified botulinum toxin that does not contain human or animal-based components. Revance successfully completed a Phase 3 program for DAXXIFY in glabellar (frown) lines and received FDA regular approval in 2022. Revance is also studying DAXXIFY across the full upper face, including glabellar lines, forehead lines and crow’s feet, as well as in three therapeutic indications - cervical dystonia, adult upper limb spasticity and pain. To accompany DAXXIFY in Rx medical aesthetics, Revance owns a unique portfolio of premium products and services for U.S. aesthetics practices, including the exclusive U.S. distribution rights to the RHA® Collection of dermal fillers, the first and only range of FDA-approved fillers for correction of dynamic facial wrinkles and folds, and the Opal fintech platform, which includes integrated smart payment, subscription and loyalty digital services. Revance has also partnered with Viatris to develop a biosimilar to BOTOX®, which would compete in the existing short-acting neuromodulator marketplace and Fosun Pharma for commercialization in China. DAXXIFY and Revance Therapeutics are registered trademarks of Revance Therapeutics, Inc. RHA resilient hyaluronic acid® and RHA® are trademarks of TEOXANE SA. BOTOX® is a registered trademark of Allergan, Inc. Show less



Neomend, Inc.

• United States
• Medical Device
• 1 - 100 Employee

• President & CEO

  • 2000 - 2002

  Sunnyvale, CA Neomend, Inc. is a medical technology company providing a variety of polymer-based surgical sealants and wound healing adhesion barriers targeting a range of tissue types, medical devices, and surgical and interventional procedures. Neomend acquired by C.R. Bard.



Prograft Medical

• Medical Equipment Manufacturing

• President & CEO

  • 1997 - 1999

  Sunnyvale, CA Private medical device company focused on minimally-invasive, catheter-based treatments of aneurysmal occlusive diseases using proprietary biomaterials. Acquired by W.L. Gore & Associates, Inc.



WL Gore & Associates, Inc.

• Business Leader, Interventional Products

  • 1995 - 1997

  Sunnyvale, CA W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body. With more than 10,500 Associates and a strong, team-oriented culture, Gore generates annual revenues of $3.7 billion. For more information, visit www.gore.com

• Vascular Business & Product Specialist

  • 1984 - 1995

  Flagstaff, AZ